Literature DB >> 10053018

Identifying families with likely genetic protective factors against Alzheimer disease.

J M Silverman1, C J Smith, D B Marin, S Birstein, M Mare, R C Mohs, K L Davis.   

Abstract

Elderly individuals who lived beyond the age of 90 years without dementia were hypothesized to have increased concentrations of genetic protective factors against Alzheimer disease (AD), conferring a reduced liability for this disease relative to less-aged nondemented elderly. However, testing this hypothesis is complicated by having to distinguish such a group from those who may lack genetic risk factors for AD, have had protective environmental exposures, or have escaped dementia for other reasons. Probands carrying genetic protective factors, however, should have relatives with lower illness rates not only for earlier-onset disease, when genetic risk factors are a strong contributing factor to the incidence of AD, but also for later-onset disease, when the role of these factors appears to be markedly diminished. AD dementia was assessed through family informants in 6,660 first-degree relatives of 1,049 nondemented probands aged 60-102 years. The probands were grouped by age (60-74, 75-89, and 90-102 years), and the cumulative survival from AD and 10-year-age-interval hazard rates of AD were calculated in their first-degree relatives. Cumulative survival from AD was significantly greater in the relatives of the oldest proband group (aged 90-102 years) than it was in the two younger groups. In addition, the reduction in the rate of illness for this group was relatively constant across the entire late life span. The results suggest that genetic factors conferring a lifelong reduced liability of AD may be more highly concentrated among nondemented probands aged >/=90 years and their relatives. Efforts to identify protective allele-bearing genes that are associated with very late-onset AD should target the families of nonagenarians and centenarians.

Entities:  

Mesh:

Year:  1999        PMID: 10053018      PMCID: PMC1377801          DOI: 10.1086/302280

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Risk of Alzheimer's disease in first-degree relatives.

Authors:  R Heun; W Maier
Journal:  Arch Gen Psychiatry       Date:  1995-04

2.  Genetic factors that protect against dementia.

Authors:  C Hirst; I M Yee; A D Sadovnick
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

3.  A validation study of the Dementia Questionnaire.

Authors:  C Kawas; J Segal; W F Stewart; M Corrada; L J Thal
Journal:  Arch Neurol       Date:  1994-09

4.  Age-specific incidence of Alzheimer's disease in a community population.

Authors:  L E Hebert; P A Scherr; L A Beckett; M S Albert; D M Pilgrim; M J Chown; H H Funkenstein; D A Evans
Journal:  JAMA       Date:  1995-05-03       Impact factor: 56.272

5.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Authors:  E H Corder; A M Saunders; N J Risch; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

6.  Evidence for familial factors that protect against dementia and outweigh the effect of increasing age.

Authors:  H Payami; K Montee; J Kaye
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

7.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

Authors:  M C Chartier-Harlin; M Parfitt; S Legrain; J Pérez-Tur; T Brousseau; A Evans; C Berr; O Vidal; P Roques; V Gourlet
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

8.  Age at onset and familial risk in Alzheimer's disease.

Authors:  G Li; J M Silverman; C J Smith; M L Zaccario; J Schmeidler; R C Mohs; K L Davis
Journal:  Am J Psychiatry       Date:  1995-03       Impact factor: 18.112

9.  Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians.

Authors:  E Sobel; J Louhija; R Sulkava; Z Davanipour; K Kontula; H Miettinen; M Tikkanen; K Kainulainen; R Tilvis
Journal:  Neurology       Date:  1995-05       Impact factor: 9.910

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  7 in total

1.  Life-long sustained mortality advantage of siblings of centenarians.

Authors:  Thomas T Perls; John Wilmoth; Robin Levenson; Maureen Drinkwater; Melissa Cohen; Hazel Bogan; Erin Joyce; Stephanie Brewster; Louis Kunkel; Annibale Puca
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan.

Authors:  Bard J Geesaman; Erica Benson; Stephanie J Brewster; Louis M Kunkel; Hélène Blanché; Gilles Thomas; Thomas T Perls; Mark J Daly; Annibale A Puca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

3.  The neuropsychological performance of nondemented Puerto Rican nonagenarians.

Authors:  José R Carrión-Baralt; Josefina Meléndez-Cabrero; Michal Schnaider Beeri; Mary Sano; Jeremy M Silverman
Journal:  Dement Geriatr Cogn Disord       Date:  2009-03-17       Impact factor: 2.959

4.  Haemoglobin A(1c) and cognitive function in very old, cognitively intact men.

Authors:  Jennifer Huang; James Schmeidler; Michal S Beeri; Clive Rosendorff; Simmi Bhatia; Rebecca K West; Irina N Bespalova; Rizalina Mavris; Jeremy M Silverman
Journal:  Age Ageing       Date:  2011-09-18       Impact factor: 10.668

5.  Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica.

Authors:  Tiffany A Greenwood; Michal S Beeri; James Schmeidler; Daniel Valerio; Henriette Raventós; Lara Mora-Villalobos; Karla Camacho; José R Carrión-Baralt; Gary Angelo; Laura Almasy; Mary Sano; Jeremy M Silverman
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Memory activation in healthy nonagenarians.

Authors:  Michal Schnaider Beeri; Hedok Lee; Hu Cheng; Daniel Wollman; Jeremy M Silverman; Isak Prohovnik
Journal:  Neurobiol Aging       Date:  2009-04-01       Impact factor: 4.673

7.  The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort description.

Authors:  Henne Holstege; Nina Beker; Tjitske Dijkstra; Karlijn Pieterse; Elizabeth Wemmenhove; Kimja Schouten; Linette Thiessens; Debbie Horsten; Sterre Rechtuijt; Sietske Sikkes; Frans W A van Poppel; Hanne Meijers-Heijboer; Marc Hulsman; Philip Scheltens
Journal:  Eur J Epidemiol       Date:  2018-10-25       Impact factor: 8.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.